Blood poisoning

Mesenchymal stem cells are being investigated as a possible to assist patient recovery following blood poisoning. Click on the link provided to find out more about the trial. It remains too early to know if the approach will be suitable. We need evidence collected in clinical trials to determine if a proposed stem cell treatment is both safe and effective.

tagged as Blood poisoning

  • Adult Stem Cell Transplantation in Severe Blood Poisining Location: Netherlands
    Overview: This trial is investigating the effect of using mesenchymal stem cells in the treatment of septic shock (or blood poisoning). The trial is being conducted by the Erasmus Medical Centre in Rotterdam and proposes to enrol 30 patients in both groups by September 2015. Participants with severe septic shock will be randomly divided into two groups. One group will receive conventional standard of care (control group). The other group will receive an intravenous injection of donated mesenchymal stem cells within six hours of their diagnosis, in addition to conventional standard of care treatment (experimental group). The experimental group will receive a further two injections of stem cells at 24 hour intervals. Participants will be monitored for complications and changes in clinical condition.
    Link to Clinical Registry
    Trial Design: Safety and Efficacy Study
    Status: Open - Recruiting
    Stem Cell: Stem Cells (unspecified)